Symbol
| GZMB
| contributors: mct/npt - updated : 21-06-2017
|
HGNC name
| granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
HGNC id
| 4709
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --over
|  
|
are independently associated with insulin resistance and also with increased cardiovascular (CV) risk in adolescent polycystic ovary syndrome patients | constitutional
|  
|  
|  
| loss of function
|
diminished the ability of a high dose of CD8(+) T cells to cause lethal graft-versus-host disease | |
Susceptibility
|
to autism spectrum disorder |
Variant & Polymorphism
|
| |
Candidate gene
Marker
| both T2DM and central obesity were predicting factors for GZMB | Therapy target
|
System | Type | Disorder | Pubmed |
immunology | autoimmune | | |
inhibiting donor-derived GzmB function may represent a promising strategy to improve GVT effect without exacerbating graft-versus-host disease |
| | |
| internalized killer cells from GzmB-deficient mice underwent a typical non-apoptotic entotic cell-in-cell death similar to that of non-cytotoxic immune cells or tumor cells |